Don't miss our holiday offer - up to 50% OFF!
BPC 157 10mg+GHK CU50mg+TB500
Price range: $179.00 through $1,599.00
Batch Number: 2026/02
Purity Percentage: 99.5
Identity Confirmation: Krause Analytics
Testing Methods: HPLC-UV/MS
Credential Line: 145211
Test Date: 09/05/2026
Research Data
Research Classification
Triple Research Peptide Blend / Multi-Peptide Research Formulation
Molecular Structure

Structure Description
This research formulation contains three structurally distinct peptide-based compounds: BPC-157, a 15-amino-acid peptide; GHK-Cu, a copper-coordinated Gly-His-Lys tripeptide complex; and TB-500, an N-terminally acetylated seven-amino-acid fragment corresponding to thymosin β4 residues 17–23. The current analytical report confirmed the identity of all three analytes by HPLC-UV-MS.
Research Discipline
Cell Biology; Peptide Biology; Vascular Biology; Fibroblast Biology; Extracellular-Matrix Biology; Copper-Peptide Research; Molecular Signaling
Molecular Formula
BPC-157: C₆₂H₉₈N₁₆O₂₂ GHK-Cu: Copper-complex formula depends on the specific coordination/speciation represented. PubChem contains GHK-Cu records including C₁₄H₂₁CuN₆O₄⁻; the laboratory COA does not specify the exact copper-complex stoichiometry. TB-500 Free Base: C₃₈H₆₈N₁₀O₁₄
Molecular Weight
BPC-157: 1419.5 g/mol GHK-Cu: Depends on the exact copper-complex species; PubChem reports 400.90 g/mol for one copper-tripeptide record. TB-500 Free Base: 889.01 g/mol
CAS Number
BPC-157: 137525-51-0 GHK-Cu / COA Reported: 49557-75-7 TB-500: 885340-08-9 The first and third identifiers correspond to BPC-157 and TB-500 respectively. The GHK-Cu CAS should be retained as COA-reported because 49557-75-7 is also associated with GHK itself in PubChem rather than uniquely defining every GHK-copper complex.
Amino Acid Sequence
BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val GEPPPGKPADDAGLV GHK-Cu: Gly-His-Lys GHK TB-500: Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln Ac-LKKTETQ
Primary Molecular Target
Multiple experimental targets/pathways; no single established shared molecular target Relevant experimental contexts include: BPC-157: vascular and cellular signaling pathways GHK-Cu: copper-dependent cellular signaling, extracellular-matrix and fibroblast-associated pathways TB-500: thymosin β4 fragment / actin-associated research context The combined formulation itself does not have a validated single molecular target.
Experimental Applications
Peptide signaling research
Fibroblast biology
Extracellular-matrix studies
Collagen-associated research
Cellular migration models
Endothelial-cell research
Vascular biology
Copper-peptide research
Cytoskeletal-associated research
Peptide structure-function studies
Cellular remodeling research
Multi-peptide interaction studies
Experimental Systems
Published research involving the individual constituents includes:
Fibroblast cell-culture systems
Endothelial-cell models
Collagen-production models
Extracellular-matrix experimental systems
Copper-peptide biochemical systems
Cellular migration models
Preclinical tissue-response models
Peptide metabolism systems
In vitro biochemical assays
These systems relate to research on the individual compounds and should not be interpreted as validation of the combined three-component formulation.
Specific Assays
HPLC-UV purity analysis
LC-MS identity analysis
Mass-spectral matching
USP endotoxin testing
Fibroblast proliferation assays
Collagen-production assays
Cell-migration assays
Extracellular-matrix expression assays
Metalloproteinase analysis
Endothelial-cell assays
Peptide stability and metabolism assays
GHK-Cu has specifically been evaluated experimentally in fibroblast proliferation and collagen-production models.
Measured Endpoints
Chromatographic purity
Component identity
Individual peptide content
Endotoxin concentration
Fibroblast proliferation
Collagen production
Extracellular-matrix remodeling
Cellular migration
Endothelial-cell response
Metalloproteinase-associated activity
Peptide stability and metabolism
For the actual OPTMZ product, the measured analytical endpoints were purity, identity, individual component content, and endotoxin concentration.
Evidence Level
Preclinical Research The scientific context for these compounds consists primarily of biochemical, cellular, animal, and other preclinical research. Evidence for the three-component formulation itself is more limited than evidence for the individual constituents.
Analytical Characterization
Independent analytical testing of OPTMZ Peptides GLOW, nominally 70 mg total, batch/lot 2026/02, by Krause Analytical reported:
Chromatographic Purity: 99.5%
BPC-157 Content: 10.1 mg
BPC-157 Label Claim: 10 mg
BPC-157 Percent of Label: 101.1%
BPC-157 Identity: Confirmed
GHK-Cu Content: 39.7 mg
GHK-Cu Label Claim: 50 mg
GHK-Cu Percent of Label: 79.3%
GHK-Cu Identity: Confirmed
TB-500 Content: 13.4 mg
TB-500 Label Claim: 10 mg
TB-500 Percent of Label: 133.6%
TB-500 Identity: Confirmed
Analysis Method: HPLC-UV-MS
Endotoxins: <0.5 EU/mL Endotoxin Method: USP
Lab Number: 205074
Project: 145211
Report Issued: May 19, 2026
The laboratory reports that values are per vial unless otherwise noted.
- Premium Quality
- Secure Payments
- Satisfaction Guarantee
- Worldwide Shipping
- Money Back Guarantee
| Pcs | Single pack, Pack of 10 |
|---|---|
| Strength | 70mg |


Reviews
There are no reviews yet.